VP Lai lauds development of biomedical industries in Taiwan
National Health Research Institutes and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceuticals Company Limited, join forces in the area of genome research to develop rare disease drugs
CORONAVIRUS/Taiwan could buy Pfizer-BioNTech vaccine through COVAX: CECC
CRISPR/Cas9: A revolutionary genomic engineering strategy in treating inherited hematopoietic disorders
AECOPD System for Precision Medicine
New season of ‘Taiwan Revealed’ launched by MOFA, Discovery Channel
Psychological stress triggers physical pain–Probing pathophysiology of fibromyalgia with translational research
Tang Prize winners discuss cytokine research, COVID-19 in video forum
ITRI and Czech Republic Embark on New Chapter in Technology Diplomacy
‘Precision health’ key to Taiwan’s future as global biomedical innovator
Biomedicine Combining with Semiconductor to Precisely Treat Parkinson’s Disease - The Development of Prospective Miniature System-on-a-Chip
A New Era of Smart Healthcare with Human-Robot Collaboration Enabling Precise and Rapid AI-aided Clinical Diagnosis Has Arrived
Ultrasonic tornado for precision medicine Improving tumor microenvironment through oxygen-loaded microbubbles trapping by acoustic vortex tweezer
President Tsai attends opening ceremony for 2020 BIO Asia-Taiwan Conference and Exhibition
Vice President Lai addresses BIO Asia–Taiwan 2020 Conference via video
